Literature DB >> 34127764

Albumin in patients with liver disease shows an altered conformation.

Margret Paar1, Vera H Fengler1, Daniel J Rosenberg2,3, Angelika Krebs4, Rudolf E Stauber5, Karl Oettl6, Michal Hammel7.   

Abstract

Human serum albumin (HSA) constitutes the primary transporter of fatty acids, bilirubin, and other plasma compounds. The binding, transport, and release of its cargos strongly depend on albumin conformation, which is affected by bound ligands induced by physiological and pathological conditions. HSA is both highly oxidized and heavily loaded with fatty acids and bilirubin in chronic liver disease. By employing small-angle X-ray scattering we show that HSA from the plasma of chronic liver disease patients undergoes a distinct opening compared to healthy donors. The extent of HSA opening correlates with clinically relevant variables, such as the model of end-stage liver disease score, bilirubin, and fatty acid levels. Although the mild oxidation of HSA in vitro does not alter overall structure, the alteration of patients' HSA correlates with its redox state. This study connects clinical data with structural visualization of albumin dynamicity in solution and underlines the functional importance of albumin's inherent flexibility.

Entities:  

Year:  2021        PMID: 34127764     DOI: 10.1038/s42003-021-02269-w

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  47 in total

1.  Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers.

Authors:  S Klammt; B Brinkmann; S Mitzner; E Munzert; J Loock; J Stange; J Emmrich; S Liebe
Journal:  Z Gastroenterol       Date:  2001-06       Impact factor: 2.000

2.  The albumin receptor effect may be due to a surface-induced conformational change in albumin.

Authors:  R G Reed; C M Burrington
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

3.  Conformational change in plasma albumin due to interaction with isolated rat hepatocyte.

Authors:  T Horie; T Mizuma; S Kasai; S Awazu
Journal:  Am J Physiol       Date:  1988-04

4.  A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin.

Authors:  D E Epps; T J Raub; F J Kézdy
Journal:  Anal Biochem       Date:  1995-05-20       Impact factor: 3.365

5.  Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin.

Authors:  J W Melten; A J Wittebrood; H J Willems; G H Faber; J Wemer; D B Faber
Journal:  J Pharm Sci       Date:  1985-06       Impact factor: 3.534

6.  Albumin-bilirubin binding mechanism.

Authors:  J Jacobsen; R Brodersen
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

7.  Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring.

Authors:  Steven C Kazmierczak; Andrey Gurachevsky; Gert Matthes; Vladimir Muravsky
Journal:  Clin Chem       Date:  2006-09-21       Impact factor: 8.327

8.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites.

Authors:  S Curry; H Mandelkow; P Brick; N Franks
Journal:  Nat Struct Biol       Date:  1998-09

Review 9.  Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis.

Authors:  Marina Naldi; Maurizio Baldassarre; Marco Domenicali; Manuela Bartolini; Paolo Caraceni
Journal:  J Pharm Biomed Anal       Date:  2017-04-18       Impact factor: 3.935

10.  The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.

Authors:  J Wilting; W F van der Giesen; L H Janssen; M M Weideman; M Otagiri; J H Perrin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

View more
  2 in total

Review 1.  Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin.

Authors:  Alessio Nocentini; Alessandro Bonardi; Simone Pratesi; Paola Gratteri; Carlo Dani; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

Review 2.  Structural changes of proteins in liver cirrhosis and consequential changes in their function.

Authors:  Nikola Gligorijević; Simeon Minić; Olgica Nedić
Journal:  World J Gastroenterol       Date:  2022-08-07       Impact factor: 5.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.